Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-25 Lochner Daniel Chief Financial Officer Shares withheld for taxes −520 $23.67 $12K 58,024
2026-09-03 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +24,250 24,250
2026-06-11 Lochner Daniel Chief Financial Officer Grant or award · Performance Stock Option (Right to Buy) +7,500 7,500
2026-03-04 Lochner Daniel Chief Financial Officer Grant or award +26,500 58,544
2026-03-04 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +24,250 24,250
2026-02-10 Lochner Daniel Chief Financial Officer Purchase +6,000 $21.61 $130K 32,044
2026-02-04 Lochner Daniel Chief Financial Officer Shares withheld for taxes −2,077 $23.22 $48K 26,044
2025-09-25 Lochner Daniel Chief Financial Officer Grant or award +5,430 28,121
2025-09-25 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +9,860 9,860
2025-02-05 Lochner Daniel Chief Financial Officer Purchase +4,617 $54.14 $250K 4,617
2025-02-04 Lochner Daniel Chief Financial Officer Grant or award +18,074 18,074
2025-02-04 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +32,862 32,862
2024-06-20 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +118,000 118,000

Page 1 of 1 · 13 trades